NATCOPHARM News Today

AstraZeneca Pharma India Reports Three-Fold Profit Surge in Q1

Copy Link

Net sales for the quarter rose by 15.1% YoY, reaching Rs.138.10 crore

• 02 June, 2023
• 1:49 PM
• less than a minute

Centre to Sell 3% Stake in Coal India Ltd, Aims to Raise ₹4,158 Crore

Copy Link

The floor price for the two-day OFS is set at ₹225 per share.

• 01 June, 2023
• 2:35 PM
• less than a minute

Lupin bags USFDA approval for Obeticholic Acid Tablets

Copy Link

In FY23, Lupin invested 7.90% of its revenue in research and development.

• 01 June, 2023
• 11:52 AM
• less than a minute

Torrent Pharma surges ~5% on posting robust performance in Q4FY23

Copy Link

During the quarter under review, the company reported an EBITDA of Rs 727 crore.

• 31 May, 2023
• 2:19 PM
• less than a minute

Markets in a bloodbath; IT, Pharma hold ground

Copy Link

On the sectoral front, Nifty Bank and Financial Services are dragging down the chart.

• 31 May, 2023
• 1:17 PM
• less than a minute

Q4FY23 Review: Torrent Pharma: Resilient performance on top line & margins

Copy Link

Recommendation: Add; Target Price: Rs 1820

• 31 May, 2023
• 11:54 AM
• less than a minute

Sun Pharma inks pact with Philogen for under-development cancer product

Copy Link

Intellectual Property Rights for Nidelgy will be retained by Philogen.

• 30 May, 2023
• 3:14 PM
• less than a minute

Q4FY23 Review: IEX Ltd: Confident of volume recovery

Copy Link

Recommendation: Add; Target Price: Rs 165

• 29 May, 2023
• 2:54 PM
• less than a minute

Q4FY23 Review: Sun Pharma: Specialty & India to lead growth momentum

Copy Link

Recommendation: Buy; Target Price: Rs 1130

• 29 May, 2023
• 2:07 PM
• less than a minute

Q4FY23 Review: JB Chemicals & Pharma: Higher GMs drive guidance upgrade for FY24

Copy Link

Recommendation: Buy; Target Price: Rs 2400

• 26 May, 2023
• 10:32 AM
• less than a minute